CoChat

The DOI matches its Crossref record; 110 of the 111 references it cites were found in a registry or an index.

Immune responses to adeno-associated virus and its recombinant vectors.

Sun, J Y, Anand-Jawa, V, Chatterjee, S, Wong, K K · 2003 · Gene Therapy

Abstract

Recombinant adeno-associated virus (rAAV) vectors have emerged as highly promising for use in gene transfer for a variety of reasons, including lack of pathogenicity and wide host range. In addition, all virus-encoded genes have been removed from standard rAAV vectors, resulting in their comparatively low intrinsic immunogenicity. For gene replacement strategies, transgenes encoded by rAAV vectors may induce less robust host immune responses than other vectors in vivo. However, under appropriate conditions, host immune responses can be generated against rAAV-encoded transgenes, raising the potential for their use in vaccine development. In this review, we summarize current understanding of the generation of both undesirable and beneficial host immune responses directed against rAAV and encoded transgenes, and how they might be exploited for optimal use of this promising vector system.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3302039

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 111 references

Research works printed but not linked: 3

  1. Stilwell J, Samulski RJ . AAV has minimal effects on cellular gene expression compared to other viruses examined using high density microarrays [abstract]. Mol Ther 2001; 3: S131.
  2. Sun J et al. Immunogenicity of a p210BCR-ABL fusion domain candidate DNA vaccine targeted to dendritic cells by an rAAV vector in vitro. Cancer Res 2002; 62: 3175–3183.
  3. Muzyczka N, Berns KI . (2001) In: Fields BN, Knipe DM, Howley, PM (eds.). Parvoviruses in Virology, 4th edn, Lippincott, Philadelphia, pp 2327–2360.

Cited by

See all 215

Metadata

Authors
Sun, J. Y., Anand-Jawa, V, Chatterjee, S., & Wong, K. K.
Affiliations
City Of Hope National Medical Center (US)
Venue
Gene Therapy
Published
2003-05-20
Volume
10
Issue
11
Pages
964-976
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W1985857615
Cited by
215
References
111
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 4 · 2020: 10 · 2019: 2 · 2018: 12 · 2017: 14 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 7 · 2012: 13
FWCI
1.06
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca075186-03)
  • National Cancer Institute (P01CA030206, CA33572, 1R01 CA75186, P30CA033572, 5P01 CA30206)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus, recombinant AAV vectors, host immune response, gene delivery vectors, vaccine development, gene replacement, vector immunogenicity
MeSH terms
Dependovirus, Animals, Antibodies, Viral, Genetic Vectors, Humans, Immunologic Memory, Immunosuppression Therapy, Parvoviridae Infections, Recombinant Proteins, Transduction, Genetic, Viral Envelope Proteins, Genetic Therapy, Transgenes, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune responses to adeno-associated virus and its recombinant vectors. https://app.cochat.ai/papers/10.1038/sj.gt.3302039
The paper
Sun, J. Y., Anand-Jawa, V, Chatterjee, S., & Wong, K. K. (2003). Immune responses to adeno-associated virus and its recombinant vectors. Gene Therapy. https://doi.org/10.1038/sj.gt.3302039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.